Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.30
Bid: 5.22
Ask: 6.30
Change: -0.12 (-2.21%)
Spread: 1.08 (20.69%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.42
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-entry drilling at the Chinarevskoye Field

19 Dec 2023 07:00

RNS Number : 1954X
Nostrum Oil & Gas PLC
19 December 2023
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

London, 19 December 2023

 

 

Commencement of re-entry drilling operations at the Chinarevskoye Field

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum", or the "Company" and together with its subsidiaries, the "Group"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, announces that it has commenced well No.301 re-entry drilling, the first of a two well re-entry drilling programme at its Chinarevskoye field, to be executed over 2023-2024. This is in line with the licence commitments and field development plan of the Company's subsidiary Zhaikmunai LLP. The programme will leverage existing wellbores to reduce costs and carries a level of uncertainties and risks as the planned subsurface targets contain multiple exploration, appraisal, and development objectives. 

The well No.301 drilling and completion duration is estimated at 90 days with start-up expected mid-2024. After drilling well No.301 the rig will move to well No.41 for a sidetrack, with a 90 day drilling and completion duration and if successful, the well will be completed and brought on line in Q3 2024.

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nog.co.uk

 

Further enquiries

Nostrum Oil & Gas Plc

Petro Mychalkiw

Chief Financial Officer

ir@nog.co.uk

 

Instinctif Partners - UK

Guy Scarborough

Vivian Lai

+ 44 (0) 207 457 2020

nostrum@instinctif.com

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG) and the Astana International Exchange (ticker symbol: NOG). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field that is being operated by a wholly-owned subsidiary of Nostrum Oil & Gas PLC - Zhaikmunai LLP, who is the sole holder of the subsoil use rights with respect to the development of the field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DRLNKFBQPBDDDBD
Date   Source Headline
31st Mar 20238:30 amRNSNostrum Oil & Gas - Capital Markets Day
27th Mar 20237:00 amRNSTR-1: form for notification of major holdings
20th Mar 20238:00 amRNS2023 production guidance
17th Mar 202310:52 amRNSHolding(s) in Company
16th Mar 20233:24 pmRNSDelisting of shares from the official list of KASE
10th Mar 202311:21 amRNSProposed acquisition of Oil & Gas assets
6th Mar 20235:57 pmRNSAppointment of auditors
3rd Mar 202311:49 amRNSNotice of Capital Markets Day
27th Feb 20232:53 pmRNSChanges in Board Committee Composition
24th Feb 20238:46 amRNSStandard form for notification of major holdings
23rd Feb 20235:24 pmRNSHolding(s) in Company
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20238:00 amRNSHolding(s) in Company
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202311:27 amRNSStandard form for notification of major holdings
15th Feb 20239:11 amRNSHolding(s) in Company
14th Feb 20234:24 pmRNSBoard changes
13th Feb 20238:47 amRNSHolding(s) in Company
10th Feb 20237:52 amRNSAdmission to trading on LSE & total voting rights
9th Feb 20234:58 pmRNSCompletion of the Restructuring
7th Feb 20233:13 pmRNSPublication of a Second Supplementary Prospectus
6th Feb 20234:48 pmRNSRestructuring, Sub-Division & Consolidation Update
30th Jan 20234:48 pmRNSUpdate on Restructuring – Required Licences
27th Jan 20237:00 amRNSOperating Update for FY 2022
20th Jan 20234:10 pmRNSProposed Extension of Scheme Longstop Date
9th Jan 20231:36 pmRNSUpdate on Restructuring – OFSI Licence Approval
6th Dec 20225:09 pmRNSPublication of a Supplementary Prospectus
28th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20224:36 pmRNSPrice Monitoring Extension
24th Nov 20224:41 pmRNSSecond Price Monitoring Extn
24th Nov 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSFinancial Results for 3Q and 9M ended 30 Sep 2022
21st Nov 202212:06 pmRNSNotice of Extension of Longstop Date
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20224:35 pmRNSPrice Monitoring Extension
11th Nov 20224:41 pmRNSSecond Price Monitoring Extn
11th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 20224:41 pmRNSSecond Price Monitoring Extn
7th Nov 20224:36 pmRNSPrice Monitoring Extension
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20224:32 pmRNSNotice of Proposed Extension of Longstop Date
28th Oct 20227:00 amRNSOperational Update for Q3 and 9M ended 30 Sep 2022
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:35 pmRNSPrice Monitoring Extension
17th Oct 20224:41 pmRNSSecond Price Monitoring Extn
17th Oct 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.